Diagnostic performance of EBUS-TBNA and its interrelation with PET-CT in patients with extra-thoracic malignancies.
E Demirdöğen, A Ursavaş, AÖ NA, G Özkaya… - Tuberkuloz ve …, 2020 - europepmc.org
Materials and methods Results of EBUS-TBNA in ETM patients with suspected MLN
metastasis were retrospectively analysed (May 2016 to July 2019). Non-malign results were
confirmed for surgery or clinical/radiological followup. Lymph nodes with a high FDG-uptake
(SUV> 2.5, MLN) were reported as suspicious for metastasis.
metastasis were retrospectively analysed (May 2016 to July 2019). Non-malign results were
confirmed for surgery or clinical/radiological followup. Lymph nodes with a high FDG-uptake
(SUV> 2.5, MLN) were reported as suspicious for metastasis.
Diagnostic performance of EBUS-TBNA and its interrelation with PET-CT in patients with extra-thoracic malignancies
ÖA Güçlü - 2020 - acikerisim.uludag.edu.tr
Introduction: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-
TBNA) is a well-established diagnostic tool for lung cancer, sarcoidosis, and suspected
metastatic extra-thoracic malignancy (ETM). Patients with primary ETM often have
hypermetabolic mediastinal/hilar lymph node enlargement in the PET-scan done for initial
staging or post treatment follow-up. We aimed to determine the diagnostic performance of
EBUS-TBNA and the relationship between PET-SUV values and diagnosis of malignancy …
TBNA) is a well-established diagnostic tool for lung cancer, sarcoidosis, and suspected
metastatic extra-thoracic malignancy (ETM). Patients with primary ETM often have
hypermetabolic mediastinal/hilar lymph node enlargement in the PET-scan done for initial
staging or post treatment follow-up. We aimed to determine the diagnostic performance of
EBUS-TBNA and the relationship between PET-SUV values and diagnosis of malignancy …